Caleres (CAL): Q1 Results Are In

The headline numbers from Caleres (NYSE: CAL) Q1 2025 did not land the way bulls were hoping. Sales came in at $614.2 million, down 6.8% year-over-year. Gross margin compressed to 45.4%, a decline of 152 basis points versus the same period last year. Diluted earnings per share checked in at $0.21 — down sharply from $0.88 in Q1 2024. And the company suspended full-year guidance entirely, citing tariff uncertainty and a difficult macro backdrop.

That is the surface read. But traders who stop there are missing the more important question: what does management actually do next, and is the market already pricing in the worst?

What the Q1 Numbers Actually Show

Famous Footwear — the company’s retail segment — posted a 6.3% sales decline with comparable sales down 4.6%. The Brand Portfolio segment, which houses names like Naturalizer, LifeStride, Dr. Scholl’s, and Blowfish Malibu, saw net sales fall 6.9% to $295.4 million versus $317.2 million a year ago. Neither segment escaped the pressure.

Gross profit came in at $278.7 million, down $30.4 million or 9.8% from Q1 2024’s $309.1 million. Management attributed the compression to lower merchandise margins and higher inventory-related costs. SG&A ran at 43.4% of net sales — up meaningfully — reflecting the pain of revenue deleverage when your fixed cost base does not shrink as fast as your top line.

Operating earnings landed at $11.6 million versus $42.8 million a year ago. That is a 72.9% decline. Net earnings attributable to Caleres shareholders came in at $6.9 million for the quarter.

February was notably weak. Trends improved in March and April — but not enough to close the gap.

The Response Plan — and Why It Matters

Here is where it gets more interesting. Management announced structural cost-cutting actions targeting a $15 million reduction in SG&A on an annualized basis, with $7.5 million expected to flow through in fiscal 2025. That is not a rounding error for a company currently generating thin operating margins. If execution holds, it meaningfully changes the earnings math in the back half of the year.

Additionally, Caleres is accelerating its sourcing diversification away from China. The company expects dollars sourced from China to represent 10% or less of total sourcing in the second half of 2025 — a significant strategic shift given the tariff environment. This is a direct response to supply chain risk, and the speed of the pivot is worth tracking closely.

Slight tangent worth noting: the DTC channel represented approximately 72% of total net sales in fiscal 2024. That structural characteristic gives Caleres more direct control over pricing and inventory positioning than a pure wholesale model — which matters when you are trying to manage margin in a soft demand environment.

Three Scenarios Worth Modeling

Bull Case: The $15M SG&A reduction executes cleanly, China sourcing exposure drops below 10% by Q3, tariff risk moderates, and consumer spending stabilizes. Comparable sales trends recover toward flat by Q3 2025. In this environment, operating leverage returns and the stock re-rates meaningfully from depressed levels. Watch for any guidance reinstatement as the key catalyst.

Base Case: Cost cuts partially offset continued top-line softness. Gross margin stabilizes in the 44%–45% range but does not recover to prior-year levels. The company exits 2025 with full-year GAAP loss per diluted share in management’s guided range of $0.13–$0.18, with adjusted EPS in the $0.55–$0.60 range. Shares remain range-bound with elevated volatility around any macro consumer data.

Bear Case: Consumer discretionary spending deteriorates further into the back half of 2025. Tariffs remain elevated. Sourcing diversification takes longer to implement than expected, squeezing margins further. SG&A cuts fail to offset revenue declines, and the full-year adjusted EPS guide of $0.55–$0.60 proves too optimistic. Stuart Weitzman integration costs — currently guided to dilute EPS by $0.60–$0.65 — compound the downside pressure.

Active Trader Framework

For traders watching CAL, the key variables to monitor are: (1) any commentary around guidance reinstatement — a suspended guide creates asymmetric reaction potential in both directions; (2) monthly comparable sales trend data as a real-time proxy for whether the March/April improvement is durable; and (3) gross margin trajectory in Q2 2025, specifically whether the China sourcing pivot begins showing up in the cost structure.

Volatility expectations should remain elevated given the suspended guidance. Position sizing accordingly. This is not a name where conviction should outpace the information available.

The broader consumer discretionary footwear space is facing the same macro headwinds — tariff exposure, softer discretionary spend, and inventory management pressure. What separates companies in this environment is execution speed on cost structure and sourcing flexibility. Caleres has identified the levers. Whether they can pull them fast enough is the question that Q2 results will start to answer.

Preparation over prediction. That is the only edge available right now.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.